Marekani - Kiingereza - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx) - candesartan cilexetil 4 mg - candesartan cilexetil tablets are indicated for the treatment of hypertension in adults and in children 1 to <17 years of age, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure

Marekani - Kiingereza - NLM (National Library of Medicine)

zydus lifesciences limited - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx) - candesartan cilexetil 4 mg - candesartan cilexetil tablets are indicated for the treatment of hypertension in adults and in children 1 to <17 years of age, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure

Ufaransa - Kifaransa - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

boiron - ilex paraguariensis pour préparations homéopathiques 2ch à 30ch et 4dh à 60dh - granules - 2ch à 30ch et 4dh à 60dh - > ilex paraguariensis pour préparations homéopathiques 2ch à 30ch et 4dh à 60dh comprimé > ilex paraguariensis pour préparations homéopathiques 2ch à 30ch et 4dh à 60dh solution buvable en gouttes > ilex paraguariensis pour préparations homéopathiques 2ch à 30ch et 4dh à 60dh poudre orale > ilex paraguariensis pour préparations homéopathiques 2ch à 30ch et 4dh à 60dh pommade > ilex paraguariensis pour préparations homéopathiques 2ch à 30ch et 4dh à 60dh (pommade à 4 % solution buvable en ampoules > ilex paraguariensis pour préparations homéopathiques 2ch à 30ch et 4dh à 60dh - pas d'indication thérapeutique

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - candesartancilexetil - tabletter - 4 mg

Ujerumani - Kijerumani - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

biologische heilmittel heel gmbh - ilex aquifolium (pot.-angaben), ilex aquifolium (pot.-angaben), ilex aquifolium (pot.-angaben), ilex aquifolium (pot.-angaben) - flüssige verdünnung zur injektion - ilex aquifolium (pot.-angaben) 0.275ml; ilex aquifolium (pot.-angaben) 0.275ml; ilex aquifolium (pot.-angaben) 0.275ml; ilex aquifolium (pot.-angaben) 0.275ml

Ujerumani - Kijerumani - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

biologische heilmittel heel gmbh - ilex aquifolium (pot.-angaben), ilex aquifolium (pot.-angaben), ilex aquifolium (pot.-angaben) - flüssige verdünnung zur injektion - ilex aquifolium (pot.-angaben) 0.367ml; ilex aquifolium (pot.-angaben) 0.367ml; ilex aquifolium (pot.-angaben) 0.367ml

Ujerumani - Kijerumani - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

staufen-pharma gmbh & co.kg - ilex aquifolium (pot.-angaben) - urtinktur - ilex aquifolium (pot.-angaben) 1.0ml

Ujerumani - Kijerumani - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

staufen-pharma gmbh & co.kg - ilex aquifolium (pot.-angaben) - streukügelchen - ilex aquifolium (pot.-angaben) 0.01g

Ujerumani - Kijerumani - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

staufen-pharma gmbh & co.kg - ilex aquifolium (pot.-angaben) - flüssige verdünnung zur injektion - ilex aquifolium (pot.-angaben) 1.1ml

Ujerumani - Kijerumani - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

weber & weber gmbh & co.kg - ilex aquifolium (pot.-angaben) - flüssige verdünnung - ilex aquifolium (pot.-angaben) 1.0ml